021-51111890
购物车（）
sales@molnova.cn
APR-246
CAS No. 5291-32-7
APR-246 ( PRIMA-1MET )
产品货号. M14875 CAS No. 5291-32-7
APR-246 (PRIMA-1MET) 是 PRIMA-1 的甲基化衍生物，可恢复突变型 p53 活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥549 | 有现货 |
|
| 10MG | ￥847 | 有现货 |
|
| 25MG | ￥1693 | 有现货 |
|
| 50MG | ￥3004 | 有现货 |
|
| 100MG | ￥4158 | 有现货 |
|
| 200MG | ￥5823 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ￥605 | 有现货 |
|
生物学信息
-
产品名称APR-246
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述APR-246 (PRIMA-1MET) 是 PRIMA-1 的甲基化衍生物，可恢复突变型 p53 活性。
-
产品描述APR-246 (PRIMA-1MET) is a methylated derivative of PRIMA-1 that restores mutant p53 activity, acts synergistically with chemotherapeutic agents to inhibit tumor cell proliferation; also restores the pro-apoptotic function to mutant TAp63γ and TAp73β in tumor cells but has less effect on TAp73α;induces mutant p53-dependent mitochondria-mediated apoptosis through activation of caspase-2 with subsequent cytochrome c release and further activation of downstream caspase-9 and caspase-3; inhibits tumor xenograft growth in vivo.Ovarian Cancer Phase 2 Clinical.
-
体外实验——
-
体内实验——
-
同义词PRIMA-1MET
-
通路Apoptosis
-
靶点MDM2-p53
-
受体p53activator|TrxR1inhibitor
-
研究领域Cancer
-
适应症Ovarian Cancer
化学信息
-
CAS Number5291-32-7
-
分子量199.25
-
分子式C10H17NO3
-
纯度>98% (HPLC)
-
溶解度DMSO: 20mg/mL （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C1C(COC)(CO)N2CCC1CC2
-
化学全称2-(Hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Shen J, et al. Oncogene. 2008 Nov 20;27(51):6571-80.
2. Bykov VJ, et al. Oncogene. 2005 May 12;24(21):3484-91.
3. R?kaeus N, et al. Oncogene. 2010 Dec 9;29(49):6442-51.
产品手册
关联产品
-
HDM-201
HDM-201 (NVP-HDM 201, Siremadlin) 是一种高效的 p53-MDM2 相互作用抑制剂，生化 IC50 为 0.13 nM，细胞 IC50 为 90 nM。
-
p53 17-26
This peptide is amino acids 17 to 26 fragment of p53, the Mdm-2 binding domain of p53 known also as p53N. This sequence contains all of the residues that contact the binding domain of Mdm-2.
-
PK-11007
一种 2-磺酰基嘧啶化合物，是一种温和的硫醇烷基化剂，对 p53 受损细胞具有抗癌活性。
